Empirical Wealth Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRS
BCM
Empirical Wealth Management's ACRS Position: Q3 2026 in Review
Empirical Wealth Management sold out of Aclaris Therapeutics (ACRS) in Q3 2026, closing a stake of 16,072 shares — an estimated $85K sold.
Empirical Wealth Management first reported a position in ACRS in Q2 2026 and held it in 1 quarter. The position peaked at $85K in Q2 2026. 166 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.
- Empirical Wealth Management reported no remaining Aclaris Therapeutics position as of Q3 2026 after selling out during the quarter.
- Empirical Wealth Management sold 16,072 Aclaris Therapeutics shares in Q3 2026, an estimated $85K.
- Empirical Wealth Management first reported a position in Aclaris Therapeutics in Q2 2026 and held it in 1 quarter.
- Empirical Wealth Management's Aclaris Therapeutics position peaked at $85K in Q2 2026.
- 166 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.
Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.